-
Product Insights
NewMeMed Diagnostics Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our MeMed Diagnostics Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. MeMed Diagnostics Ltd (MeMed) is a developer of diagnostic solutions for inflammatory and infectious diseases. The company’s products include ImmunoXpert, which is an in-vitro diagnostic test used for diagnosing the difference between bacterial and viral infections. It provides ImmunoPoC, a hand-held instrument used for the diagnosis of bacterial versus viral infections. MeMed offers services in varied fields including molecular...
-
Company Profile
Canva Pty Ltd – Company Profile
Canva Pty Ltd (Canva) is a provider of graphic design Software as a Service. The company's product includes for mobile, pro, education, pricing, download app, enterprise and nonprofits. It helps to create social media graphics and presentations. The company offers various designs for blogging and e-books, documents, education, events, inspiration and marketing tools, social media and email headers as well as social media posts. Canva offers designs such as album covers, banners, comic strips, wattpad covers, certificates, letterheads, newsletters, presentations,...
Add to Basket -
Track & Monitor
Environment Sustainability in Healthcare: Automated Immunoassay Analyzer
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Track & Monitor
Artificial Intelligence in Healthcare: Automated Immunoassay Analyzer
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Track & Monitor
Cloud in Healthcare: Automated Immunoassay Analyzer
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Track & Monitor
Internet of Things in Healthcare: Automated Immunoassay Analyzer
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Product Insights
Immunochemistry Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Spot test kits intended generally for rapid diagnosis, with immediate results, through immuno assays. Some of the tests carried out using immunochemistry rapid test include rabies virus test, allergenic food proteins, and enteric infection. The immunochemistry rapid tests and POC pipeline market research report provides comprehensive information about the immunochemistry rapid tests and POC pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Company Insights
Ping An Insurance – Digital Transformation Strategies
Ping An Insurance has been focusing on using artificial intelligence, cloud, blockchain and big data to digitally transform its operations. The annual ICT spending of Ping An Insurance was estimated at $8.8 billion for 2021. A major share of this spending is earmarked for acquiring software, ICT services and hardware from vendors. Ping An Insurance is an integrated financial conglomerate providing insurance, banking, and investment products and services to individuals and corporate clients. The group offers a range of life...
-
Company Insights
Future Unicorns in Healthtech
Based on the GlobalData Machine Learning Model’s proprietary ranking of 10,000 top startups, 120 Healthtech startups have been shortlisted globally, with 50 of them predicted to become future unicorns. The 10k top startups in the Scorecard are spread over 70 countries with the US accounting for half of them, followed by China. Positive sentiments in the news, continued VC investments, increase in hiring clubbed with growing Healthtech mentions in Company Filings indicate that the Healthtech sector has high interest for...
-
Product Insights
COVID 19 point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
COVID-19 point of care (POC) tests are used to detect the presence or activity of COVID-19 antigen. This segment includes rapid tests and point of care tests for COVID-19. The COVID-19 POC tests pipeline products report provides comprehensive information about the COVID 19 point of care tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report also provides information on the pipeline products...